William Robert Elder
CIK 1828068 · View on SEC EDGAR ↗
First SEC filing: Feb. 13, 2026 · Latest: Feb. 13, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | CRVO | P | 2,500 | $8.32 | $20,800 | 12,500 Direct | +25.00% | Acquired | -69.2% (price as of 2026-08-21) |
| Nov. 17, 2025 | CRVO | P | 1,000 | $8.45 | $8,450 | 10,000 Direct | +11.11% | Acquired | -69.7% (price as of 2026-08-21) |
| Nov. 12, 2025 | CRVO | P | 3,500 | $7.44 | $26,040 | 9,000 Direct | +63.64% | Acquired | -65.6% (price as of 2026-08-21) |
| May 14, 2025 | CRVO | P | 4,233 | $8.46 | $35,811 | 5,500 Direct | +334.10% | Acquired | -69.7% (price as of 2026-08-21) |
| Aug. 27, 2024 | CRVO | P | 1,000 | $18.16 | $18,160 | 1,267 Direct | +374.53% | Acquired | -85.9% (price as of 2026-08-21) |
| March 18, 2022 | CRVO | P | 5,000 | $0.50 | $2,500 | 5,000 Direct | — | Acquired | -93.2% (price as of 2026-08-21) |
| Nov. 17, 2020 | CRVO | P | 5,000 | $0.63 | $3,150 | 15,000 Direct | +50.00% | Acquired | -94.6% (price as of 2026-08-21) |
| Nov. 16, 2020 | CRVO | P | 10,000 | $0.67 | $6,700 | 10,000 Direct | — | Acquired | -94.9% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | CRVO | Stock Option (Right to Buy) | Common Stock (30,000) | $4.80 | Feb. 11, 2036 | 30,000 | Acquired |
| Feb. 4, 2025 | CRVO | Stock Option (Right to Buy) | Common Stock (27,000) | $2.30 | Feb. 4, 2035 | 27,000 | Acquired |
| Jan. 26, 2024 | CRVO | Stock Option (Right to Buy) | Common Stock (16,000) | $9.05 | Jan. 26, 2034 | 16,000 | Acquired |
| Sept. 15, 2023 | CRVO | Stock Option (Right to Buy) | Common Stock (16,000) | $5.33 | Sept. 15, 2033 | 16,000 | Acquired |
| April 18, 2022 | CRVO | Series C Convertible Preferred Stock [F1] | Common Stock | — | — | 100 | Disposed |
| March 18, 2022 | CRVO | Series C Convertible Preferred Stock [F1] | Common Stock (5,000) | $0.50 | — | 5,000 | Acquired |
| Jan. 27, 2022 | CRVO | Stock Option (Right to Buy) | Common Stock (305,743) | $0.24 | Jan. 27, 2032 | 305,743 | Acquired |
| March 1, 2021 | CRVO | Stock Option (Right to Buy) | Common Stock (87,684) | $1.11 | March 1, 2031 | 87,684 | Acquired |
| March 1, 2021 | CRVO | Stock Option (Right to Buy) | Common Stock (62,522) | $1.11 | March 1, 2031 | 62,522 | Acquired |
| Sept. 22, 2020 | CRVO | Stock Option (Right to Buy) [F1] | Common Stock (70,000) | $0.82 | Sept. 22, 2030 | 70,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $467,100 | — | — | $42,606 | $176,564 | — | — | $686,270 |
| 2024 | $406,475 | — | — | $103,008 | $142,266 | — | — | $651,749 |
| 2023 | $292,782 | — | — | $60,800 | $114,771 | — | — | $468,353 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.